|
|
Nanoco Group PLC - Sales Analysis Snapshot
Business Description This Report provides a comprehensive Sales & Margin summary analysis for Nanoco Group PLC Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.
Nanoco Group PLC Formerly known as Evolutec Group PLC. The Group's principal activity is providing research and development of biopharmaceutical products. It develops drugs for allergy, inflammation and autoimmune disease. Products include rEV131, rEV576, rEV598 and anti-tick vaccine. The Group operates in The United Kingdom, Rest of Europe and North America.
Not the Report you are looking for? Click here for more browsing options.
Layout and Content of a Typical Report
|
|
|
|
|